All In Biotech

Drug Trial Radar · NCT02933281

MTBVAC Study in Adults With and Without Latent Tuberculosis Infection in South Africa

MTBVAC Phase 1b/2a Randomized, Double-blind, Active-controlled,Safety, Immunogenicity, and Dose-escalation Study in Adults With and Without Latent Tuberculosis Infection in South Africa

Last checked: Nov 19, 2026Latest source record: Feb 27, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 144 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

144

Actual

Start

May 14, 2018

Primary completion

Sep 5, 2021

Study completion Sep 5, 2021

Sponsor

Lead sponsor
International AIDS Vaccine InitiativeResearch network
Sponsor type
Research network
Collaborators
Biofabri, S.L; Universidad de Zaragoza; South African Tuberculosis Vaccine Initiative
First posted
Oct 14, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

MTBVAC at four dose levels: 5 x 10\^3 CFU, 5 x 10\^4 CFU, 5 x 10\^5 CFU, and 5 x 10\^6 CFU. The active control is BCG (5 x 10\^5 CFU). Participants will receive a single dose of MTBVAC or BCG revaccination administered intradermally on Study Day 0.

Conditions

  • Tuberculosis

Interventions

  • MTBVACBiological

    Escalating dose levels (5 x 10\^3 CFU, 5 x 10\^4 CFU, 5 x 10\^5 CFU, and 5 x 10\^6 CFU

  • BCGBiological

    BCG 5 x 10\^5 CFU

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and reactogenicity of MTBVAC at escalating dose levels compared to BCG vaccine by assessing number of participants with AEs and SAEsTime frame: Study Days 0 to Day 365

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • SATVI: Worcester

    Worcester, South Africa

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.